Pevita Pearce

Johnson & Johnson Bets Big on In Vivo CAR-T: A Strategic Pivot Toward Scalable Immunology

• Treatment Innovations

Johnson & Johnson Bets Big on In Vivo CAR-T: A Strategic Pivot Toward Scalable Immunology

Pevita Pearce July 31, 2026

In a significant move that underscores the pharmaceutical industry’s shifting focus, Johnson & Johnson (J&J) has secured...

Read More Read more about Johnson & Johnson Bets Big on In Vivo CAR-T: A Strategic Pivot Toward Scalable Immunology

Beyond the Facelift: How Regenerative Medicine and Plasma Resurfacing are Redefining Facial Rejuvenation

• Breast Cancer Surgery and Reconstruction

Beyond the Facelift: How Regenerative Medicine and Plasma Resurfacing are Redefining Facial Rejuvenation

Pevita Pearce July 30, 2026

For decades, the surgical facelift has been the gold standard for addressing the physiological hallmarks of aging:...

Read More Read more about Beyond the Facelift: How Regenerative Medicine and Plasma Resurfacing are Redefining Facial Rejuvenation

Crystalys Therapeutics Secures $130 Million Series B Funding to Advance Gout Therapy Dotinurad Towards Commercialization

• Medical Research and Clinical Trials

Crystalys Therapeutics Secures $130 Million Series B Funding to Advance Gout Therapy Dotinurad Towards Commercialization

Pevita Pearce July 26, 2026

San Francisco, CA – [Insert Date] – Crystalys Therapeutics, a clinical-stage biopharmaceutical company, has successfully closed a...

Read More Read more about Crystalys Therapeutics Secures $130 Million Series B Funding to Advance Gout Therapy Dotinurad Towards Commercialization

The Genetic Blueprint for Survival: How Tree Genomics is Rewriting the Future of Our Forests

• Genomics and Precision Medicine

The Genetic Blueprint for Survival: How Tree Genomics is Rewriting the Future of Our Forests

Pevita Pearce July 25, 2026

In the quiet canopy of an Appalachian ridge or the bustling quad of a university campus, a...

Read More Read more about The Genetic Blueprint for Survival: How Tree Genomics is Rewriting the Future of Our Forests

Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

• Medical Research and Clinical Trials

Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Pevita Pearce July 25, 2026

LA JOLLA, CA – May 12, 2025 – In a landmark study poised to redefine our understanding...

Read More Read more about Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Sisters Who Cancer Together: A Story of Strength, Support, and Sisterhood

• Survivorship and Post-Treatment

Sisters Who Cancer Together: A Story of Strength, Support, and Sisterhood

Pevita Pearce July 24, 2026

By Editorial Staff November 05, 2025 “We are survivors. We are sisters. And together, we are proof...

Read More Read more about Sisters Who Cancer Together: A Story of Strength, Support, and Sisterhood

A New Era for Preventive Health: Breast Cancer Canada Welcomes Federal Advisory Committee on Preventive Health Services

• Patient Advocacy and Support

A New Era for Preventive Health: Breast Cancer Canada Welcomes Federal Advisory Committee on Preventive Health Services

Pevita Pearce July 23, 2026

OTTAWA – In a significant move toward modernizing the nation’s approach to disease prevention and early intervention,...

Read More Read more about A New Era for Preventive Health: Breast Cancer Canada Welcomes Federal Advisory Committee on Preventive Health Services

The New Frontier of Multiple Myeloma: Navigating the BCMA Revolution and Post-CAR T-Cell Relapse

• Clinical Oncology Education

The New Frontier of Multiple Myeloma: Navigating the BCMA Revolution and Post-CAR T-Cell Relapse

Pevita Pearce July 23, 2026

The landscape of multiple myeloma treatment has shifted from a paradigm of chronic disease management to one...

Read More Read more about The New Frontier of Multiple Myeloma: Navigating the BCMA Revolution and Post-CAR T-Cell Relapse

Breakthrough HIV Therapy Poised to Revolutionize Treatment with Once-Weekly Dosing

• Medical Research and Clinical Trials

Breakthrough HIV Therapy Poised to Revolutionize Treatment with Once-Weekly Dosing

Pevita Pearce July 22, 2026

San Francisco, CA – [Insert Date] – The landscape of human immunodeficiency virus (HIV) treatment is on...

Read More Read more about Breakthrough HIV Therapy Poised to Revolutionize Treatment with Once-Weekly Dosing

Crystalys Therapeutics Secures $130M Series B to Propel Gout Drug Dotinurad Toward Western Markets

• Treatment Innovations

Crystalys Therapeutics Secures $130M Series B to Propel Gout Drug Dotinurad Toward Western Markets

Pevita Pearce July 22, 2026

By Jonathan Gardner | July 22, 2026 In a significant display of investor confidence, emerging biotech firm...

Read More Read more about Crystalys Therapeutics Secures $130M Series B to Propel Gout Drug Dotinurad Toward Western Markets